AMED
Price
$100.99
Change
+$0.01 (+0.01%)
Updated
Aug 14 closing price
Capitalization
3.32B
73 days until earnings call
SPT
Price
$14.11
Change
+$0.16 (+1.15%)
Updated
Aug 15 closing price
Capitalization
829.88M
74 days until earnings call
Interact to see
Advertisement

AMED vs SPT

Header iconAMED vs SPT Comparison
Open Charts AMED vs SPTBanner chart's image
Amedisys
Price$100.99
Change+$0.01 (+0.01%)
Volume$1.06M
Capitalization3.32B
Sprout Social
Price$14.11
Change+$0.16 (+1.15%)
Volume$1.57M
Capitalization829.88M
AMED vs SPT Comparison Chart in %
Loading...
AMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMED vs. SPT commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a Hold and SPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (AMED: $100.99 vs. SPT: $14.11)
Brand notoriety: AMED and SPT are both not notable
AMED represents the Hospital/Nursing Management, while SPT is part of the Packaged Software industry
Current volume relative to the 65-day Moving Average: AMED: 177% vs. SPT: 214%
Market capitalization -- AMED: $3.32B vs. SPT: $829.88M
AMED [@Hospital/Nursing Management] is valued at $3.32B. SPT’s [@Packaged Software] market capitalization is $829.88M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $92.61B to $0. The market cap for tickers in the [@Packaged Software] industry ranges from $324.27B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $3.97B. The average market capitalization across the [@Packaged Software] industry is $8.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMED’s FA Score shows that 0 FA rating(s) are green whileSPT’s FA Score has 0 green FA rating(s).

  • AMED’s FA Score: 0 green, 5 red.
  • SPT’s FA Score: 0 green, 5 red.
According to our system of comparison, AMED is a better buy in the long-term than SPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMED’s TA Score shows that 4 TA indicator(s) are bullish while SPT’s TA Score has 4 bullish TA indicator(s).

  • AMED’s TA Score: 4 bullish, 4 bearish.
  • SPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SPT is a better buy in the short-term than AMED.

Price Growth

AMED (@Hospital/Nursing Management) experienced а +0.05% price change this week, while SPT (@Packaged Software) price change was +1.22% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.81%. For the same industry, the average monthly price growth was +0.50%, and the average quarterly price growth was +6.42%.

The average weekly price growth across all stocks in the @Packaged Software industry was +0.47%. For the same industry, the average monthly price growth was +7.13%, and the average quarterly price growth was +15.47%.

Reported Earning Dates

AMED is expected to report earnings on Oct 29, 2025.

SPT is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Hospital/Nursing Management (+1.81% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

@Packaged Software (+0.47% weekly)

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMED($3.32B) has a higher market cap than SPT($830M). AMED YTD gains are higher at: 11.235 vs. SPT (-54.054). AMED has higher annual earnings (EBITDA): 239M vs. SPT (-43.76M). AMED has more cash in the bank: 337M vs. SPT (102M). SPT has less debt than AMED: SPT (37.5M) vs AMED (451M). AMED has higher revenues than SPT: AMED (2.4B) vs SPT (418M).
AMEDSPTAMED / SPT
Capitalization3.32B830M400%
EBITDA239M-43.76M-546%
Gain YTD11.235-54.054-21%
P/E Ratio39.30N/A-
Revenue2.4B418M575%
Total Cash337M102M330%
Total Debt451M37.5M1,203%
FUNDAMENTALS RATINGS
AMED: Fundamental Ratings
AMED
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
36
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMEDSPT
RSI
ODDS (%)
Bearish Trend 3 days ago
36%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
44%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
37%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
35%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
47%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
58%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
51%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
28%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
AMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINIX48.280.27
+0.56%
MFS International Intrinsic Value I
JHQTX20.06N/A
N/A
JPMorgan Hedged Equity 3 I
BFIIX18.31-0.01
-0.05%
Baron FinTech Institutional
CSAZX15.08-0.02
-0.13%
Columbia Global Opportunities Inst
MWOBX50.76-0.07
-0.14%
MFS Global Growth B

AMED and

Correlation & Price change

A.I.dvisor tells us that AMED and ENSG have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and ENSG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMED
1D Price
Change %
AMED100%
N/A
ENSG - AMED
25%
Poorly correlated
+0.10%
TALK - AMED
24%
Poorly correlated
+1.19%
OPCH - AMED
23%
Poorly correlated
-0.32%
MD - AMED
21%
Poorly correlated
+3.22%
CYH - AMED
21%
Poorly correlated
N/A
More